Sources
Everything we rely on, named.
UlCure does not do original research. Everything we publish is drawn from clinical guidelines and studies that other people wrote, and we think you should be able to see them. Below is every source behind our plans and our articles, with the year it was published, what we took from it, and how much weight we put on it. If you find one that is out of date, tell us — contact@ulcure.clinic — and we will say so publicly on this page.
International clinical guidance
WHO Model List of Essential Medicines, 23rd list
World Health Organization · 2023
- What we use it for
- Which medicines a country's health system is expected to keep available. We use it to check that anything our plans describe is something an ordinary Kenyan pharmacy should be able to stock, rather than something only a private hospital carries.
- How strong we think it is
- Very strong for availability, and deliberately silent about you. It says what should be on the shelf in a country — not what is right for one person, which only a clinician can judge.
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner P and colleagues, in Gut (BMJ) · 2022
- What we use it for
- The international consensus on how H. pylori infection is managed end to end — when testing is worth doing, the shape and length of a course, and why a follow-up test matters. Most of what our plans explain about sequence and timing traces back to this document.
- How strong we think it is
- Strong. It is a consensus of specialists reading the whole published evidence base, not a single study. It is written for European practice, so we treat its assumptions about what is available locally with care.
Professional society guidance
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
Chey WD and colleagues, American Journal of Gastroenterology (American College of Gastroenterology) · 2024
- What we use it for
- The current professional-society position in the United States. We use it for which tests confirm an infection, why a confirmatory follow-up test is recommended, and how resistance changes what is recommended.
- How strong we think it is
- Strong and recent — this is the most up-to-date document we rely on. It is written for American patients and American pharmacies, so we never carry its assumptions about cost or availability into Kenyan copy.
Kenyan and African sources
Kenya Essential Medicines List, 2023 edition
Ministry of Health, Republic of Kenya · 2023
- What we use it for
- The Kenyan counterpart to the WHO list. It is the reason we describe what a Kenyan pharmacy is expected to have rather than what an international guideline assumes you can get.
- How strong we think it is
- Strong for what should be available in Kenya, and the most locally relevant document we have. It is a list, not treatment guidance — it tells you what exists, never what you personally should take.
Helicobacter pylori Management in Africa: A Survey of Diagnostic, Treatment, and Related Resources
Mashiko S and colleagues, in Helicobacter · 2024
- What we use it for
- What testing and follow-up actually look like across African health systems, as opposed to what international guidance assumes. It is why we are careful about which tests we tell you to ask for.
- How strong we think it is
- Moderate. A survey of resources is not a clinical trial, and coverage across countries is uneven. We use it to check our assumptions about access, not to make clinical claims.
Prevalence and patterns of peptic ulcer disease in Africa: a systematic review and meta-analysis
Abdu SM and colleagues, in BMC Gastroenterology · 2025
- What we use it for
- How common peptic ulcer disease is across Africa, and in whom. It is the basis for the general statements we make about how widespread this problem is on the continent.
- How strong we think it is
- Moderate, and this is where we are most careful. Pooled prevalence figures across very different studies carry wide uncertainty — which is exactly why we do not publish a single headline percentage anywhere on this site.
Kenyan prices we quote on this site
Every price figure that appears anywhere on this website is listed here, so you can check it rather than take our word for it.
- H. pylori stool antigen test
- KES 2,000 – 4,000
- Household water filter
- KES 2,000 – 5,000
- Ulcure Plan
- KES 499
- Pona AI
- KES 999
- Wellness call, 30 minutes
- KES 1,499
Quoted on our H. pylori testing and Kenya guide pages.
Quoted on our water safety page.
Our own price. One payment, nothing renews.
Our own price. One payment, nothing renews.
Our own price. One payment, nothing renews.
Be careful with the first two. They are indicative ranges for things other people sell, they move, and we have not yet published a dated receipt for each one — so treat them as a rough guide for what to budget, not a quote. Our own three prices are exact. If any figure here is wrong, tell us and we will correct it and note the change on this page.
What we do not have
We do not have a clinician on staff and we do not claim any of these organisations endorse us. Citing a guideline is not the same as being approved by the people who wrote it, and we will never suggest otherwise. If that matters to you — and it reasonably might — take our plan to a pharmacist or a clinician and check it against what they say. That is what it is designed for.
We are not a clinic — on purpose
We do not diagnose you and we do not sell you medicine. We explain what the published guidelines say, so you can walk into the chemist or the clinic knowing exactly what to ask.
That is a deliberate choice, not a shortcut. Diagnosing needs a test. Prescribing needs a licence. We have neither, we will never pretend we do, and a KES 499 app that claimed either would be lying to you. What we can do is make sure that when you finally sit in front of someone qualified, you are not starting from "my stomach hurts".
Always see a doctor for severe or worsening symptoms. Maumivu yakizidi pata ushauri wa Daktari. Full health disclaimer
Nobody pays us to cite one source over another. See who pays us.